Violich Capital Management, Inc. Pfizer Inc Transaction History

Violich Capital Management, Inc.

$769 Million
Q3 2024

A detailed history of Violich Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Violich Capital Management, Inc. holds 47,037 shares of PFE stock, worth $1.23 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

47,037

Previous 46,869 0.36%

Holding current value

$1.23 Million

Previous $1.31 Million 3.81%

% of portfolio

0.18%

Previous 0.18%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$27.7 - $31.39 $4,653 - $5,273	168 Added 0.36%	47,037 $1.36 Million
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $381,877 - $438,517	14,750 Added 45.92%	46,869 $1.3 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $55,709 - $72,360	-2,132 Reduced 6.22%	32,119 $925,000
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $28,090 - $34,807	614 Added 1.83%	34,251 $1.77 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $401,802 - $516,149	10,237 Added 43.75%	33,637 $1.45 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $25,400 - $29,800	-800 Reduced 3.31%	23,400 $859,000
Q4 2019 Jan 16, 2020	SELL	$32.92 - $37.36 $8,888 - $10,087	-270 Reduced 1.1%	24,200 $948,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $32,490 - $42,130	-1,000 Reduced 3.93%	24,470 $879,000
Q2 2019 Jul 22, 2019	SELL	$36.98 - $41.52 $36,980 - $41,520	-1,000 Reduced 3.78%	25,470 $0
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $57,714 - $61,529	-1,750 Reduced 6.2%	26,470 $960,000
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $14,260 - $15,709	-460 Reduced 1.6%	28,220 $1.01 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,680	28,680 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.

Account

Violich Capital Management, Inc. Pfizer Inc Transaction History